These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 31052493)

  • 1. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
    Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
    Mondal S; Thompson PR
    Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.
    Bereta G; Goulas T; Madej M; Bielecka E; Solà M; Potempa J; Gomis-Rüth FX
    Protein Sci; 2019 Mar; 28(3):478-486. PubMed ID: 30638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
    Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
    Front Immunol; 2021; 12():716250. PubMed ID: 34737738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
    Vitkov L; Hannig M; Minnich B; Herrmann M
    Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Secreted Bacterial Peptidylarginine Deiminase Can Neutralize Human Innate Immune Defenses.
    Stobernack T; du Teil Espina M; Mulder LM; Palma Medina LM; Piebenga DR; Gabarrini G; Zhao X; Janssen KMJ; Hulzebos J; Brouwer E; Sura T; Becher D; van Winkelhoff AJ; Götz F; Otto A; Westra J; van Dijl JM
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment.
    Mansouri P; Mansouri P; Behmard E; Najafipour S; Kouhpayeh SA; Farjadfar A
    Int J Biol Macromol; 2024 Oct; 278(Pt 3):134576. PubMed ID: 39127273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
    Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
    J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
    Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
    J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
    Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
    Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.
    Montgomery AB; Kopec J; Shrestha L; Thezenas ML; Burgess-Brown NA; Fischer R; Yue WW; Venables PJ
    Ann Rheum Dis; 2016 Jun; 75(6):1255-61. PubMed ID: 26209657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
    Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
    Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.
    Stobernack T; Glasner C; Junker S; Gabarrini G; de Smit M; de Jong A; Otto A; Becher D; van Winkelhoff AJ; van Dijl JM
    J Proteome Res; 2016 Dec; 15(12):4532-4543. PubMed ID: 27712078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revamped role for approved drug: integrative computational and biophysical analysis of saquinavir's peptidyl arginine deiminase 4 inhibition for rheumatoid arthritis.
    Thirugnanasambandham I; Jupudi S; Roychowdhury P; Karri VVSR; Madhunapantula SRV; Singh SK; Subramaniyan V; Kuppusamy G
    Biochem J; 2024 Oct; 481(20):1379-1393. PubMed ID: 39312210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
    Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
    Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
    Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
    Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies.
    Pérez-Pérez ME; Nieto-Torres E; Bollain-Y-Goytia JJ; Delgadillo-Ruíz L
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase.
    Goulas T; Mizgalska D; Garcia-Ferrer I; Kantyka T; Guevara T; Szmigielski B; Sroka A; Millán C; Usón I; Veillard F; Potempa B; Mydel P; Solà M; Potempa J; Gomis-Rüth FX
    Sci Rep; 2015 Jul; 5():11969. PubMed ID: 26132828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.
    Bielecka E; Scavenius C; Kantyka T; Jusko M; Mizgalska D; Szmigielski B; Potempa B; Enghild JJ; Prossnitz ER; Blom AM; Potempa J
    J Biol Chem; 2014 Nov; 289(47):32481-7. PubMed ID: 25324545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photochemical Control of Protein Arginine Deiminase (PAD) Activity.
    Mondal S; Parelkar SS; Nagar M; Thompson PR
    ACS Chem Biol; 2018 Apr; 13(4):1057-1065. PubMed ID: 29517899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.